Jura Announces Favorable Award on Costs under the Settlement Agreement Arbitration
CALGARY, Alberta, April 03, 2025 (GLOBE NEWSWIRE) -- Jura Energy Corporation ("Jura" or the "Company") is pleased to announce that it has received a favorable ruling on costs in its…
Zefiro Founder and CEO Appears on Orphan and Marginal Wells Panel in Fort Worth, Texas Led by JPMorganChase Head of Operational Decarbonization
The annual event, which is hosted by the Neeley School of Business and was sponsored by JPMorgan and Double Eagle Energy Holdings, provides a forum for leaders across the energy…
Innospec Schedules First Quarter 2025 Earnings Release and Conference Call
ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market…
LGI Homes Reports March and First Quarter 2025 Home Closings and Announces Date for First Quarter Earnings Conference Call
THE WOODLANDS, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 426 homes in March 2025. The Company closed 996 homes during the…
Anne Whitaker Appointed as Non-Executive Director
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive…
BESTYRELSESMEDLEMMERS, DIREKTØRERS ELLER NÆRTSTÅENDE PERSONERS HANDEL MED STRATEGIC PARTNERS AKTIER
April 03, 2025 18:16 ET | Source: Strategic Partners A/S Strategic Partners A/S Please visit: Our Sponsor
LanzaTech Acknowledges Receipt of Letter
CHICAGO, April 04, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today acknowledged that the Company has received a non-binding…
Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 03 04 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Form 8.3 – Primary Health Properties
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time…